Next Article in Journal
Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications
Previous Article in Journal
Efficiency of IL-6 in Early Prognosis and Follow-Up in Critically Ill Patients with Septic Shock
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Reconstructive Surgery in the Elderly: A Case Report on Maintaining the Quality of Life in a Patient with Vulvar Dermatofibrosarcoma Protuberans

1
Department of Gynecology and Obstetrics, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-045 Olsztyn, Poland
2
Scientific Circle of the Department of Gynecology and Obstetrics, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-045 Olsztyn, Poland
3
Department of Gynecology and Gynecologic Oncology, Medical University of Białystok, Skłodowskiej Str. 24A, 15-276 Białystok, Poland
*
Author to whom correspondence should be addressed.
Diseases 2024, 12(12), 299; https://doi.org/10.3390/diseases12120299
Submission received: 24 September 2024 / Revised: 12 November 2024 / Accepted: 18 November 2024 / Published: 22 November 2024

Abstract

Background: Dermatofibrosarcoma protuberans (DFSP) is a rare proliferative condition representing skin sarcomas known to locally recur yet very rarely known to metastasize. A typical characteristic is trunk localization, making vulvar occurrences an exception. Complete resection is the primary treatment. Case Report: We present an unusual case of twice-recurrent vulvar DFSP in a 92-year-old woman. Wide local excision with tumor-negative margins (R0 resection) of a grapefruit-sized mass was followed by a rhomboid skin flap transplantation to address a substantial skin deficit at the post excision site. At 14-month follow-up, no signs of recurrence were present, all wounds were healed, and the esthetic results were assessed as highly adequate. Conclusions: This study is an argument for the role of reconstructive surgery in patients of advanced age undergoing oncological procedures; skin transplantations should be considered regardless of the patient’s age. We also provide an updated review on vulvar DFSP.

1. Introduction

Dermatofibrosarcoma protuberans (DFSP) is an uncommon skin and/or soft tissue malignancy known to locally recur yet very rarely known to metastasize. Usually, it is a slow-growing, firm, multinodular lesion. When borne in the skin, it usually stems from the dermis and subcutaneous tissue, but not from the epidermis. As a soft tissue tumor, it may involve subcutaneous fat or connective tissue [1,2]. Eisen and Tallini state that DFSP originates in the reticular dermis [3]. Fibroblasts or histiocytes are believed to be the cells of its origin, yet the neoplasm was frequently referred to as a fibrohistiocytic tumor without defining the precise histogenesis [3,4,5,6,7,8,9]. Other likely precursors are perineural cells [10,11]. It was first recognized as a separate entity independently by Sherwell and Taylor in 1890 and later described in much detail by Darier and Ferrand in 1924; nonetheless, the full term ‘dermatofibrosarcoma protuberans’ was proposed by Hoffmann in 1925 [12,13,14,15]. The 2012 guideline by the National Comprehensive Cancer Network states that DFSP is an uncommon, low-to-intermediate-grade sarcoma of fibroblast origin [16].
The incidence of DFSP is low. Yet, even if infrequent, DFSP represents the most common dermal sarcoma (about 1% of all soft tissue sarcomas), more than 1% of all head and neck malignant tumors, and 7% of all head and neck sarcomas [17,18], making the vulvar presentation a rarity with fewer than 100 cases described in the literature to date. Information on incidence patterns of DFSP is still somewhat limited. In a series of 240 patients from the Memorial Sloan-Kettering Cancer Center, New York, NY, USA, there was equal distribution between men and women [19]. Population-based data from the Surveillance, Epidemiology, and End Results (SEER) Program for 1973 to 2002 showed that overall annual incidences of DFSP in the United States were 4.2 per million inhabitants. [20]. Data from other SEER Program registries reviewed for the period from 1992 through 2004 demonstrated the overall DFSP incidence of 4.5 per million inhabitants per year [21]. This relative rarity of DFSP is reflected in the lack of prospective scientific evidence.
We report on a 92-year-old female in good general condition with locally (re-)recurrent DFSP, successfully managed using a well-established approach [22,23]—a wide local excision (WLE) followed by a rhomboid skin flap transplantation. In this case, no postoperative radiation therapy was applied. There were no treatment-related cosmetic or functional issues observed. Our patient is another example of maintaining quality of life and functionality in a patient of a particularly advanced age.

2. Case Study

In July 2023, a 92-year-old woman (gravida 2, para 2) presented to the gynecologic oncology outpatient department for consultation regarding a vulvar mass that had reappeared six months earlier and grew quite quickly since then. The patient was normosthenic, not cognitively impaired, and had good control of her long-term arterial hypertension, managed effectively by her family doctor. Her vulvar problem appeared first in 2011 when she underwent a WLE for an 8 × 9 cm mass, and the anatomopathological diagnosis of DFSP was established. She was asymptomatic for another 6 years, and a local de novo growth of 10 × 7 cm in size was observed in 2017. Again, it was managed with complete local resection, and a microscopic diagnosis of DFSP was reconfirmed. During both these procedures, inguinal lymphadenectomies were not performed, as radiologically local lymphatic drainage remained unaffected. Asked about the noticeable sizes of those tumors, the patient explained that they were completely painless and therefore evoked a certain tolerance in her. Her both previous postoperative anatomopathological examinations described a DFSP of typical appearance with low mitotic indices as judged by low Ki67/MIB1 staining in immunohistochemistry.
A gynecological examination revealed a grapefruit-sized (10 × 9 cm) nodular tumor located between the upper border of her mons pubis, left labium, and left inguinal ligament, with a reduced access to the vaginal introitus (Figure 1A). Extensive skin scarring above the mass was noted. No inguinal lymphadenopathies were detected. The tumor had a somewhat uneven surface but had well-defined borders, was painless at palpation, and presented a small elliptical skin erosion on its left aspect. Yet this erosion did not bleed.
Recurrent disease is surgically more challenging because one often observes fixation of the tumor to deeper structures [24], such as fascia. This is so because previous surgeries usually excised most of the topical subcutaneous tissue. In our patient, the tumor mass was still slightly mobile in reference to the surrounding tissues. Her preoperative A-P chest radiograph showed no suspicious pulmonary opacities, and her abdominal ultrasound was normal. A careful evaluation by palpation of her nodal status, as well as MRI scan, was negative. All in all, the process of medical decisionmaking in her case was based on the following premises: her substantially advanced age; non-fibrosarcomatous DFSP with low mitotic indices in postoperative examinations from her first DFSP surgery and from her first recurrence surgery; actual recurrence not exceeding 10 cm in size (Figure 1A), no signs of local or distant metastatic disease; preserved mobility of the well-circumscribed lesion at palpation; no weight change over the past few months; lack of history of metabolic conditions directly affecting wound healing (such as poorly controlled diabetes mellitus or obesity); and a likely skin deficit following the planned surgery due to previous extensive excisions.
In July 2023, another WLE was performed. A 20-French Foley catheter was placed preoperatively in the urinary bladder. The vulvar skin was incised starting from the mons pubis bilaterally around the lesion. Gross margins of at least 3.0 cm of healthy tissue from the mass were carefully maintained, this based on research that in such instances truly safe, histologically defined margins average 1.6 cm [25]. Moreover, it has been demonstrated that adequate surgical margins as a single modality were associated with 100% local control in all primary DFSPs [26]. Remnants of adipose tissue under the lesion were dissected, and three separate vascular pedicles nourishing the mass were closed and resected with bipolar coagulation (Figure 1B). Intraoperatively, tumor-negative margins (R0 resection) were confirmed. The final specimen was submitted to histopathological examination, and a diagnosis of recurrent DFSP without fibrosarcomatous change was made.
As anticipated, the extent of the wound area after WLE required covering it with a skin graft. To loosen skin tension around the wound, skin mobilization was first performed. The lower abdominal rhomboid skin flap was then raised from the mons pubis skin, preserving the blood supply from abdominal branches of the left superficial epigastric and pudendal arteries. The flap was transposed and secured with resorbable polyglactin No. 1 sutures. The edges of the skin were closed tension-free with non-resorbable polyamide No. 2/0 Blair–Donati stitches for cosmesis. After the procedure, the vaginal introitus regained its symmetry (Figure 1C).
The patient has been followed up for 14 months. At the 5-month checkup, she was well, and the vulvar region and inguinal areas were unsuspected. A transvaginal ultrasound exam showed a small retroverted uterus, a minimal-width endometrium, and atrophied ovaries. No signs of recurrence were noted. The patient expressed her satisfaction with the anatomic results. The esthetic results were assessed as highly adequate (Figure 1D); on the Visual Analog Scale, the patient gave a score of 8 (possible rating: 0–10), and the operating surgeon (first author) gave 7 points.

3. Discussion

Our patient is likely to be the oldest case of recurrent vulvar DFSP reported in the literature. Earlier, Soltan described an 83-year-old patient [27], whereas Edelweiss and Malpica reported on a 76-year-old one [1]. However, the dimensions of the presented patient’s tumor, although substantial, were not extreme. The largest lesion (of unknown location) was reported in the Navarrete-Dechent study as having a diameter of 49 cm [28]. In relation to the specific site, the largest so far and, in fact, giant vulvar DFSPs were reported in a Serbian (18 × 10 × 8 cm) and an American (20 × 16 × 13 cm) study [29,30]. As mentioned [19], vulvar location is rare for DFSP (less than 2% of the cases). There have been approximately 60 such women described until 2019 [29]. The largest published series coming from singular institutions were from the M.D. Anderson Cancer Center, Houston, TX, USA, (13 vulvar DFSPs) [1], and from the Mayo Clinic, Rochester, MN, Brigham and Women’s Hospital, Boston, MA, and The Johns Hopkins Hospital, Baltimore, MD combined (11 vulvar DFSPs) [31]. We identified many other, mostly singular, cases of vulvar location reports [27,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53], and two reviews [54,55]. The available data from the literature on 43 cases of vulvar DFSP treatment modalities and results have been summarized in Table 1. Consequently, our current count of vulvar DFSPs is 94 reported patients; thus, they are not so exceedingly rare.
The message from the reviews can be summarized as follows. From the Nguyen reappraisal of 54 patients, the tumor histology was uniformly consistent with typical, i.e., low-to-intermediate-grade DFSP, the site of the labia majora was the most commonly affected (53.7%), lesions showed slow to minimal change in size, and no associated lymphadenopathies were reported [54]. In the Mancari report on 68 patients, the indolent nature of the lesion was observed, and the wide use of WLE and partial or total vulvectomy was confirmed [55]. Bertolli et al. applied the complete circumferential peripheral and deep margin assessment, or CCPDMA, technique to remove a vulvar tumor [43]. One modern and attractive alternative to a highly mutilating radical vulvectomy is WLE, which offers the removal of a vulvar tumor with a necessary margin of healthy tissue. In cases of large-sized tumors, however, the excision may leave a significant open wound area. Thus, large postoperative skin defects may result in impaired wound healing, skin tension, and psychological and sexual problems. In particular, the apparent proximity of the anus to the vulvar area carries an increased risk of complications including wound infections [56]. The WLE technique for vulvar DFSP removal provides rather safe, large, negative surgical margins, whereas Mohs micrographic surgery, or MMS, may be considered in exposed areas for its precision and limited cosmetic damage [37,57]. Surgical results may be further improved by postoperative radiotherapy [58,59], which may also be indicated in cases with positive margins or in inoperable patients. Based on recent advancements in cancer genetics, COL1A1-PDGFB gene mutations have been revealed in DFSP. This has resulted in a new approach to DFSP treatment with imatinib methylate, an αPDGFR-targeted therapy for unresectable or metastatic tumors [60].
As with other locations, rare fibrosarcomatous transformation and lung metastases from vulvar DFSPs have been reported [1,45,51]. The patient of Neff et al. had left inguinal lymph node involvement, or local disease spread [30]. Therefore, the evaluation of oncologic risk factors in our patient was mandatory. Advanced age, relatively quick recent growth, and large recurrent tumor size were considered risk factors for potential sarcomatous change. Yet the intraoperative verification of the tumor margins’ negativity (R0 resection) was reassuring. With a history of repeated excision of a large area of hypogastric skin, we focused on the proper covering of the resultant skin defect. Papers by Caretto et al., Lee et al., and Lazarro et al. were all studied, and the rhomboid skin flap was chosen for repair [56,61,62]. Skin flap transplantations in mature patients have been reported to provide good results with no local discomfort with normal activities, including sexual activity, and pleasing esthetic outcome [61,62].

4. Conclusions

Vulvar DFSPs are known to locally recur yet very rarely known to metastasize. Usually, a DFSP is a slow-growing, firm, multinodular lesion. Wide radial surgical excision with at least 3 cm margins is the gold standard curative treatment for a localized DFSP but may result in functional impairment or cosmetic disfigurement. We presented a case of twice-recurrent vulvar DFSP in a patient of a highly advanced age, which required the advent of the lower abdominal rhomboid skin flap to cover a skin defect resulting from complete tumor resection. We propose that skin flap transplantations should be considered regardless of the patient’s age.

Author Contributions

Conceptualization, M.J. (Marcin Jozwik); operative procedure, M.J. (Marcin Jozwik); writing—original draft preparation, M.J. (Marcin Jozwik), K.B., Z.O. and M.J. (Maciej Jozwik); final editing, M.J. (Marcin Jozwik) and M.J. (Maciej Jozwik); funding acquisition, M.J. (Marcin Jozwik). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

As a retrospective descriptive case study supplemented by a review of the literature, this work did not require approval from the local IRB.

Informed Consent Statement

Informed consent was obtained from the patient for the publication of her medical data and anonymized photographs.

Data Availability Statement

All research data are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Edelweiss, M.; Malpica, A. Dermatofibrosarcoma protuberans of the vulva: A clinicopathologic and immunohistochemical study of 13 cases. Am. J. Surg. Pathol. 2010, 34, 393–400. [Google Scholar] [CrossRef] [PubMed]
  2. Chen, S.; Xiong, L.; Zhao, L.; Li, Y.; Li, L. Survival outcomes and prognostic factors of dermatofibrosarcoma protuberans: A population-based retrospective cohort analysis. Dermatol. Surg. 2023, 49, 825–831. [Google Scholar] [CrossRef] [PubMed]
  3. Eisen, R.N.; Tallini, G. Metastatic dermatofibrosarcoma protuberans with fibrosarcomatous change in the absence of local recurrence. A case report of simultaneous occurrence with a malignant giant cell tumor of soft parts. Cancer 1993, 72, 462–468. [Google Scholar] [CrossRef] [PubMed]
  4. O’Dowd, J.; Laidler, P. Progression of dermatofibrosarcoma protuberans to malignant fibrous histiocytoma: Report of a case with implications for tumor histogenesis. Hum. Pathol. 1988, 19, 368–370. [Google Scholar] [CrossRef]
  5. Aiba, S.; Tabata, N.; Ishii, H.; Ootani, H.; Tagami, H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br. J. Dermatol. 1992, 127, 79–84. [Google Scholar] [CrossRef]
  6. Hisaoka, M.; Okamoto, S.; Morimitsu, Y.; Tsuji, S.; Hashimoto, H. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Virchows Arch. 1998, 433, 323–329. [Google Scholar] [CrossRef]
  7. Sasaki, M.; Ishida, T.; Horiuchi, H.; MacHinami, R. Dermatofibrosarcoma protuberans: An analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression. Pathol. Int. 1999, 49, 799–806. [Google Scholar] [CrossRef]
  8. Kholová, I.; Ryska, A.; Dedic, K. Composite tumor consisting of dermatofibrosarcoma protuberans and giant cell fibroblastoma associated with intratumoral endometriosis. Report of a case. Pathol. Res. Pract. 2001, 197, 263–270. [Google Scholar] [CrossRef]
  9. Romano, R.C.; Fritchie, K.J. Fibrohistiocytic Tumors. Clin. Lab. Med. 2017, 37, 603–631. [Google Scholar] [CrossRef]
  10. Hashimoto, K.; Brownstein, M.H.; Jakobiec, F.A. Dermatofibrosarcoma protuberans. A tumor with perineural and endoneural cell features. Arch. Dermatol. 1974, 110, 874–885. [Google Scholar] [CrossRef]
  11. Alguacil-Garcia, A.; Unni, K.K.; Goellner, J.R. Histogenesis of dermatofibrosarcoma protuberans. An ultrastructural study. Am. J. Clin. Pathol. 1978, 69, 427–434. [Google Scholar] [CrossRef] [PubMed]
  12. Sherwell, S. Morphea. Arch. Dermatol. 1890, 8, 72–73. [Google Scholar]
  13. Taylor, R.W. Sarcomatous tumors resembling in some respects keloids. Arch. Dermatol. 1890, 8, 384–387. [Google Scholar]
  14. Darier, J.; Ferrand, M. Dermatofibromes progressifs et récidivants ou fibrosarcomes de la peau. Ann. Dermatol. Syphiligr. 1924, 5, 545–562. [Google Scholar]
  15. Hoffmann, E. I. Über das knollentreibende Fibrosarkom der Haut (Dermatofibrosarkoma protuberans). Dermatol. Z. 1925, 43, 1–28. [Google Scholar] [CrossRef]
  16. Miller, S.J.; Alam, M.; Andersen, J.S.; Berg, D.; Bichakjian, C.K.; Bowen, G.M.; Cheney, R.T.; Glass, L.F.; Grekin, R.C.; Ho, A.L.; et al. Dermatofibrosarcoma protuberans. J. Natl. Compr. Canc. Netw. 2012, 10, 312–318. [Google Scholar] [CrossRef]
  17. Angouridakis, N.; Kafas, P.; Jerjes, W.; Triaridis, S.; Upile, T.; Karkavelas, G.; Nikolaou, A. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Head Neck Oncol. 2011, 3, 5. [Google Scholar] [CrossRef]
  18. Mallett, K.E.; Almubarak, S.; Claxton, R.M.; Ferguson, P.C.; Griffin, A.M.; Rose, P.S.; Wunder, J.S.; Tsoi, K.; Houdek, M.T. Preoperative risk factors for fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Anticancer Res. 2022, 42, 105–108. [Google Scholar] [CrossRef]
  19. Fields, R.C.; Hameed, M.; Qin, L.X.; Moraco, N.; Jia, X.; Maki, R.G.; Singer, S.; Brennan, M.F. Dermatofibrosarcoma protuberans (DFSP): Predictors of recurrence and the use of systemic therapy. Ann. Surg. Oncol. 2011, 18, 328–336. [Google Scholar] [CrossRef]
  20. Criscione, V.D.; Weinstock, M.A. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J. Am. Acad. Dermatol. 2007, 56, 968–973. [Google Scholar] [CrossRef]
  21. Rouhani, P.; Fletcher, C.D.M.; Devesa, S.S.; Toro, J.R. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases. Cancer 2008, 113, 616–627. [Google Scholar] [CrossRef] [PubMed]
  22. Khatri, V.P.; Galante, J.M.; Bold, R.J.; Schneider, P.D.; Ramsamooj, R.; Goodnight, J.E.J. Dermatofibrosarcoma protuberans: Reappraisal of wide local excision and impact of inadequate initial treatment. Ann. Surg. Oncol. 2003, 10, 1118–1122. [Google Scholar] [CrossRef] [PubMed]
  23. Sun, L.M.; Wang, C.J.; Huang, C.C.; Leung, S.W.; Chen, H.C.; Fang, F.M.; Huang, E.Y.; Lee, S.P. Dermatofibrosarcoma protuberans: Treatment results of 35 cases. Radiother. Oncol. 2000, 57, 175–181. [Google Scholar] [CrossRef] [PubMed]
  24. Rutkowski, P.; Dębiec-Rychter, M.; Nowecki, Z.; Michej, W.; Symonides, M.; Ptaszynski, K.; Ruka, W. Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection. J. Eur. Acad. Dermatol. Venereol. 2011, 25, 264–270. [Google Scholar] [CrossRef]
  25. Popov, P.; Böhling, T.; Asko-Seljavaara, S.; Tukiainen, E. Microscopic margins and results of surgery for dermatofibrosarcoma protuberans. Plast. Reconstr. Surg. 2007, 119, 1779–1784. [Google Scholar] [CrossRef]
  26. Heuvel, S.T.; Suurmeijer, A.; Pras, E.; Van Ginkel, R.J.; Hoekstra, H.J. Dermatofibrosarcoma protuberans: Recurrence is related to the adequacy of surgical margins. Eur. J. Surg. Oncol. 2010, 36, 89–94. [Google Scholar] [CrossRef]
  27. Soltan, M.H. Dermatofibrosarcoma protuberans of the vulva. Case report. Br. J. Obstet. Gynaecol. 1981, 88, 203–205. [Google Scholar] [CrossRef]
  28. Navarrete-Dechent, C.; Mori, S.; Barker, C.A.; Dickson, M.A.; Nehal, K.S. Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: A systematic review. JAMA Dermatol. 2019, 155, 361–369. [Google Scholar] [CrossRef]
  29. Jeremic, J.; Stefanovic, A.; Jeremic, K.; Jovic, M.; Pilic, I.; Cvetkovic, A.; Stojanovic, M. Giant dermatofibrosarcoma protuberans vulvae: Rare clinical presentation and literature review. J. BUON 2019, 24, 1289–1295. [Google Scholar]
  30. Neff, R.; Collins, R.; Backes, F. Dermatofibrosarcoma protuberans: A rare and devastating tumor of the vulva. Gynecol. Oncol. Rep. 2019, 28, 9–11. [Google Scholar] [CrossRef]
  31. Jahanseir, K.; Xing, D.; Greipp, P.T.; Sukov, W.R.; Keeney, G.L.; Howitt, B.E.; Schoolmeester, J.K. PDGFP rearrangements in dermatomyosarcoma protuberans of the vulva. A study of 11 cases including myxoid and fibrosarcomatous variants. Int. J. Gynecol. Pathol. 2018, 37, 537–546. [Google Scholar] [CrossRef]
  32. De Chadarévian, J.P.; Coppola, D.; Billmire, D.F. Bednar tumor pattern in recurring giant cell fibroblastoma. Am. J. Clin. Pathol. 1993, 100, 164–166. [Google Scholar] [CrossRef] [PubMed]
  33. Vanni, R.; Faa, G.; Dettori, T.; Melis, G.B.; Dumanski, J.P.; O’Brien, K.P. A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma. Virchows Arch. 2000, 437, 95–100. [Google Scholar] [CrossRef] [PubMed]
  34. Algarra-Sahuquillo, J.; Llombart, B.; Serra-Guillen, C.; Sanmartin, O. Slow Mohs micrographic surgery for the treatment of genital dermatofibrosarcoma protuberans: A single-center series of 5 cases. Dermatol. Surg. 2024, 50, 764–765. [Google Scholar] [CrossRef]
  35. Agress, R.; Figge, D.C.; Tamimi, H.; Greer, B. Dermatofibrosarcoma protuberans of the vulva. Gynecol. Oncol. 1983, 16, 288–291. [Google Scholar] [CrossRef]
  36. Bock, J.E.; Andreasson, B.; Thorn, A.; Holck, S. Dermatofibrosarcoma protuberans of the vulva. Gynecol. Oncol. 1985, 20, 129–135. [Google Scholar] [CrossRef]
  37. Barnhill, D.R.; Boling, R.; Nobles, W.; Crooks, L.; Burke, T. Vulvar dermatofibrosarcoma protuberans. Gynecol. Oncol. 1988, 30, 149–152. [Google Scholar] [CrossRef]
  38. Panidis, D.; Rousso, D.; Achparaki, A.; Georgiadis, H.; Vlassis, G. Recurrence of dermatofibrosarcoma protuberans of the vulva. A clinical, histological, and ultrastructural study. Eur. J. Gynaecol. Oncol. 1993, 14, 182–186. [Google Scholar]
  39. Ghorbani, R.P.; Malpica, A.; Ayala, A.G. Dermatofibrosarcoma protuberans of the vulva: Clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature. Int. J. Gynecol. Pathol. 1999, 18, 366–373. [Google Scholar] [CrossRef]
  40. Ohlinger, R.; Kühl, A.; Schwesinger, G.; Bock, P.; Lorenz, G.; Köhler, G. Dermatofibrosarcoma protuberans of the vulva. Acta Obstet. Gynecol. Scand. 2004, 83, 685–686. [Google Scholar] [CrossRef]
  41. Olejek, A.; Kozak-Darmas, I.; Gajewska, A.; Gabriel, A.; Zajecki, W. Dermatofibrosarcoma protuberans of the vulva. Wiad. Lek. 2008, 61, 232–235. [Google Scholar] [PubMed]
  42. Oge, T.; Benedicic, C.; Tamussino, K.; Regauer, S. Dermatofibrosarcoma protuberans of the vulva: A case report. BMJ Case Rep. 2009, 2009, bcr0720080377. [Google Scholar] [CrossRef] [PubMed]
  43. Bertolli, E.; Bretchbuhl, E.R.; Camarço, W.R.; Campagnari, M.; Molina, A.S.; Baiocchi, G.; Macedo, M.P.; Pinto, C.A.; Cunha, I.W.; Neto, J.P. Dermatofibrosarcoma protuberans of the vulva: Margins assessment and reconstructive options—A report of two cases. World J. Surg. Oncol. 2014, 12, 399. [Google Scholar] [CrossRef]
  44. Gilani, S.; Al-Khafaji, B. Dermatofibrosarcoma protuberans of the vulva: A mesenchymal tumour with a broad differential diagnosis and review of literature. Pathologica 2014, 106, 338–341. [Google Scholar] [PubMed]
  45. Vathiotis, I.A.; Psichogiou, E.; Syrigos, K.N.; Kotteas, E.A. Lung metastasis from fibrosarcomatous dermatofibrosarcoma protuberans of the vulva: A rare case report. J. Low. Genit. Tract Dis. 2018, 22, 85–87. [Google Scholar] [CrossRef]
  46. Zemni, I.; Sassi, I.; Boujelbene, N.; Haddad, S.; Doghri, R.; Chargui, R.; Rahal, K. Vulvar Darier-Ferrand dermatofibrosarcoma: Unusual localization of a rare tumor. Pan Afr. Med. J. 2019, 33, 46. [Google Scholar] [CrossRef]
  47. Goyal, L.D.; Garg, P.; Kaur, M.; Sharma, D. Recurrent dermatofibrosarcoma protuberans of the vulva: A rare occurrence and review of literature. J. Fam. Reprod. Health 2021, 15, 136–140. [Google Scholar] [CrossRef]
  48. Zizi-Sermpetzoglou, A.; Savvaidou, V.; Fournogerakis, S.; Moustou, E.; Konstantidelli, M.; Vlachakos, N. Dermatofibrosarcoma protuberans of the mons pubis. Eur. J. Gynaecol. Oncol. 2012, 33, 537–539. [Google Scholar]
  49. Wiszniewska, J.; Roy, A.; Masand, R.P. Myxoid dermatofibrosarcoma protuberans of the vulva: Case report of a rare variant in an unusual location, with unusual morphologic and immunohistochemical features. Am. J. Dermatopathol. 2016, 38, 226–230. [Google Scholar] [CrossRef]
  50. Moodley, M.; Moodley, J. Dermatofibrosarcoma protuberans of the vulva: A case report and review of the literature. Gynecol. Oncol. 2000, 78, 74–75. [Google Scholar] [CrossRef]
  51. Soergel, T.M.; Doering, D.L.; O’connor, D. Metastatic dermatofibrosarcoma protuberans of the vulva. Gynecol. Oncol. 1998, 71, 320–324. [Google Scholar] [CrossRef] [PubMed]
  52. Veld, E.A.H.I.; van Coevorden, F.; Grünhagen, D.J.; Smith, M.J.; van Akkooi, A.C.J.; Wouters, M.W.J.M.; Hayes, A.J.; Verhoef, C.; Strauss, D.C.; van Houdt, W.J. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated? Cancer 2019, 125, 735–741. [Google Scholar] [CrossRef]
  53. Karlen, J.R.; Johnson, K.; Kashkari, S. Dermatofibrosarcoma protuberans of the vulva. A case report. J. Reprod. Med. 1996, 41, 267–269. [Google Scholar] [PubMed]
  54. Nguyen, A.H.; Detty, S.Q.; Gonzaga, M.I.; Huerter, C. Clinical features and treatment of dermatofibrosarcoma protuberans affecting the vulva: A literature review. Dermatol. Surg. 2017, 43, 771–774. [Google Scholar] [CrossRef] [PubMed]
  55. Mancari, R.; Cioffi, R.; Magazzino, F.; Attademo, L.; Sant’angelo, M.; Taccagni, G.; Mangili, G.; Pignata, S.; Bergamini, A. Dermatofibrosarcoma protuberans of the vulva: A review of the MITO Rare Cancer Group. Cancers 2024, 16, 222. [Google Scholar] [CrossRef]
  56. Caretto, A.A.; Servillo, M.; Tagliaferri, L.; Lancellotta, V.; Fragomeni, S.M.; Garganese, G.; Scambia, G.; Gentileschi, S. Secondary post-oncologic vulvar reconstruction—A simplified algorithm. Front. Oncol. 2023, 13, 1195580. [Google Scholar] [CrossRef]
  57. Allen, A.; Ahn, C.; Sangüeza, O.P. Dermatofibrosarcoma protuberans. Dermatol. Clin. 2019, 37, 483–488. [Google Scholar] [CrossRef]
  58. Dagan, R.; Morris, C.G.; Zlotecki, R.A.; Scarborough, M.T.; Mendenhall, W.M. Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am. J. Clin. Oncol. 2005, 28, 537–539. [Google Scholar] [CrossRef]
  59. Fionda, B.; Loperfido, A.; Di Stefani, A.; Lancellotta, V.; Paradisi, A.; De Angeli, M.; Cappilli, S.; Rossi, E.; Caretto, A.A.; Zinicola, T.; et al. The role of postoperative radiotherapy in the management of dermatofibrosarcoma protuberans: A multidisciplinary systematic review. J. Clin. Med. 2024, 13, 1798. [Google Scholar] [CrossRef]
  60. Iwasaki, T.; Yamamoto, H.; Oda, Y. Current update on the molecular biology of cutaneous sarcoma: Dermatofibrosarcoma protuberans. Curr. Treat. Options Oncol. 2019, 20, 29. [Google Scholar] [CrossRef]
  61. Lee, P.K.; Choi, M.S.; Ahn, S.T.; Oh, D.Y.; Rhie, J.W.; Han, K.T. Gluteal fold V-Y advancement flap for vulvar and vaginal reconstruction: A new flap. Plast. Reconstr. Surg. 2006, 118, 401–406. [Google Scholar] [CrossRef] [PubMed]
  62. Lazzaro, L.; Guarneri, G.F.; Rampino Cordaro, E.; Bassini, D.; Revesz, S.; Borgna, G.; Parodi, P.C. Vulvar reconstruction using a ‘V-Y’ fascio-cutaneous gluteal flap: A valid reconstructive alternative in post-oncological loss of substance. Arch. Gynecol. Obstet. 2010, 282, 521–527. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A) Clinical presentation of the second recurrence of DFSP in a 92-year-old woman. (B) The intraoperative situation following wide local excision, or WLE. (C) The immediate postoperative appearance of skin closures. (D) The appearance of the healed hypogastric and vulvar skin at the 5-month follow-up.
Figure 1. (A) Clinical presentation of the second recurrence of DFSP in a 92-year-old woman. (B) The intraoperative situation following wide local excision, or WLE. (C) The immediate postoperative appearance of skin closures. (D) The appearance of the healed hypogastric and vulvar skin at the 5-month follow-up.
Diseases 12 00299 g001
Table 1. Cumulative chronologic data from the literature on vulvar DFSP cases, treatment modalities, and results. NED, no evidence of disease; NIG, no information given; WLE, wide local excision.
Table 1. Cumulative chronologic data from the literature on vulvar DFSP cases, treatment modalities, and results. NED, no evidence of disease; NIG, no information given; WLE, wide local excision.
PublicationCasesPatient’s
Age (yrs.)
LocationTumor Size
(cm)
Surgical TreatmentFollow-Up (Months)RecurrenceOutcome
Soltan, (1981) [27]183left labia minor and major8.5 × 3.5excisional biopsy 6noNED
Agress et al. (1983) [35]161upper left labium major and mons pubis4 × 8WLE, followed by radical vulvectomy65after 5 years and later after 5 monthsNED
Bock et al. (1985) [36]152mons pubis8 × 8 × 2WLE6noNED
Barnhill et al. (1988) [37]145anterior right vulva lateral to the clitoris.1 × 1WLE, followed by radical hemivulvectomy with removal of the clitoris.54after 3 yearsNED
De Chadarévian et al. (1993) [32]11left labium 8 × 2.5undefined excision29after 12 monthsNED
Panidis et al. (1993) [38]130right labium major1 × 2WLE, followed by total vulvectomy6after 6 monthsNIG
Karlen et al. (1996) [53]136vulva5WLE27noNED
Soergel et al. (1998) [51]147left labia3 × 3 × 3local excision followed by partial radical vulvectomy, followed by WLE213 occurrences of DFSP over approximately a 3-year period, later after 16 months, and after the next 5 monthsmetastatis
Ghorbani et al. (1999) [39]436–69 (mean 54)left paraclitoral area (1 case), right labium major (1 case), left labium major (1 case), and mons pubis (1 case)1.2–5.0WLE (3), refused (1)2403NED (2 cases), alive with disease (1 case), dead of other causes (1 case)
Moodley & Moodley (2000) [50]139left labium major8 × 12reexcision with 3 cm lateral margin and depth down to the pubic periosteum and fascia of the urogenital diaphragm3noNED
Vanni et al. (2000) [33]139centered in the vulva, extending to the perineal raphe6 × 6WLE29noNED
Ohlinger et al. (2004) [40]136left side of the vulva2.3 × 2.8excisional biopsy1085 recurrencescomplete tumor clearance was achieved only after 5 additional surgeries.
Olejek et al. (2008) [41]149vulvan/an/an/an/aNIG
Oge et al. (2009) [42]156vulva3 × 3wide and deep local excision15recurrenceNED
Edelweiss & Malpica (2010) [1]1323–76 (mean 46)right labium major (6), right labium major/crural fold (1), right labium major/mons pubis (1), left labium major (2), paraclitoral (2), and mons pubis (1)1.2 to 15 (median, 4)excisional biopsy (3), excisional biopsies followed by WLE (7), WLE (2), excisional biopsy followed by radical vulvectomy (1) 2 to 4447alive with disease (2), dead of other causes (1), dead of disease (1), NED (9)
Zizi-Sermpetzoglou et al. (2012) [48]166mons pubis8 × 5WLEn/an/aNED
Bertolli et al. (2014) [43]228, 57mons pubis (1), right labium major (1)5 × 5, 2 × 2partial vulvectomy with clitoris preservation (1), complete circumferential and peripheral deep margin assessment and WLE (1)40 and 10no (2)NED (2)
Gilani & Al-Khafaji, (2014) [44]161left mons pubis N/Aexcisional biopsy and 2 subsequent resections12noNED
Wiszniewska et al. (2016) [49]144right labia5.0 × 3.5 × 3.0wide excision with positive margins and subsequent re-excision with negative margins18noNED
Vathiotis et al. (2018) [45]172right labium majorN/AWLE48yeslung metastasis
Jeremic et al. (2019) [29]155mons pubis, clitoris and upper half of labia majora18 × 10 × 8radical tumor excision followed by soft tissue defect reconstruction18nodead of other causes
Neff et al. (2019) [30]157mons pubis and left labium major20 × 15 radical vulvectomy with vertical rectus abdominis myocutaneous flap12noNED
Zemni et al. (2019) [46]147left labium major 5 × 4 × 3.5WLE1noNIG
Goyal et al. (2021) [47]135upper part of right labium major5 × 6WLE242 recurrencesNED
Algarra-Sahuquillo et al. (2024) [34]344, 49, 13right labium major (1 case), left labia major and minor, clitoris (1 case), and pubis (1 case)2 × 1; 6 × 4.5; 6 × 5Slow Mohs Micrographic Surgery171; 67; 67noNED
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jozwik, M.; Bednarczuk, K.; Osierda, Z.; Jozwik, M. Reconstructive Surgery in the Elderly: A Case Report on Maintaining the Quality of Life in a Patient with Vulvar Dermatofibrosarcoma Protuberans. Diseases 2024, 12, 299. https://doi.org/10.3390/diseases12120299

AMA Style

Jozwik M, Bednarczuk K, Osierda Z, Jozwik M. Reconstructive Surgery in the Elderly: A Case Report on Maintaining the Quality of Life in a Patient with Vulvar Dermatofibrosarcoma Protuberans. Diseases. 2024; 12(12):299. https://doi.org/10.3390/diseases12120299

Chicago/Turabian Style

Jozwik, Marcin, Katarzyna Bednarczuk, Zofia Osierda, and Maciej Jozwik. 2024. "Reconstructive Surgery in the Elderly: A Case Report on Maintaining the Quality of Life in a Patient with Vulvar Dermatofibrosarcoma Protuberans" Diseases 12, no. 12: 299. https://doi.org/10.3390/diseases12120299

APA Style

Jozwik, M., Bednarczuk, K., Osierda, Z., & Jozwik, M. (2024). Reconstructive Surgery in the Elderly: A Case Report on Maintaining the Quality of Life in a Patient with Vulvar Dermatofibrosarcoma Protuberans. Diseases, 12(12), 299. https://doi.org/10.3390/diseases12120299

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop